文献速递血液净化与透析

患者对更长或更频繁中心血透方案的偏好:多中心离散选择研究

Patient Preferences for Longer or More Frequent In-Center Hemodialysis Regimens: A Multicenter Discrete Choice Study.
PubMed 文献 · Am J Kidney Dis · 2021-10-23

该多中心离散选择研究纳入英国5个肾脏中心183例维持性血透患者,评估患者对更长(4.5小时)或更频繁(每周4次)血透方案相对标准方案(每周3次、每次4小时)的偏好。38.3%患者始终选择标准方案;生存率提高、生活质量改善、减少液体限制需求及避免血管通路并发症均显著影响选择更长或更频繁方案。模型预测27.1%会选择每周3次 longer方案,34.3%会选择每周4次4小时方案。

要点

  • 38.3%患者始终偏好标准方案(每周3次、每次4小时)。
  • 生存率、生活质量、液体限制和通路并发症显著影响方案选择。
  • 年轻、疲劳、有通路并发症史、无心衰、路程短者更倾向每周4次。

核心结论

  • 预测的更长或更频繁血透方案接受度显著高于当前临床实际使用情况。
  • 需要更稳健的临床有效性数据,并在透析方案选择中更充分考虑患者意愿。

研究设计与样本

  • 离散选择实验:先呈现情景,再向患者展示12个治疗选择集,并附不同临床影响信息。
  • 纳入英国5个肾脏中心维持性透析≥1年的肾衰竭患者183例,平均年龄63.7岁,平均透析龄4.7年。

主要发现

  • 38.3%(70/183)患者始终选择每周3次、每次4小时的标准方案。
  • 生存率提高、生活质量改善、减少液体限制需求及避免额外通路并发症均显著与选择更长或更频繁方案相关。
  • 年轻、疲劳、既往通路并发症史、无心力衰竭及到透析中心路程较短与偏好每周4次相关。
  • 患者愿意以最多2年生命换取避免每周4次方案或通路并发症。
  • 应用现有文献的治疗获益与危害后,完全调整模型显示27.1%会选择每周3次更长方案,34.3%会选择每周4次4小时方案;年轻疲劳且住所近的患者对应估计为23.5%和62.5%。

关键数值与推荐

  • 更长方案定义为4.5小时;更频繁方案定义为每周4次;对照为标准方案每周3次、每次4小时。
  • 预测接受度基于现有文献的治疗获益与危害估计,并经完全调整模型计算。

临床怎么用

  • 临床决策中应纳入患者对透析时长和频率的偏好,而非仅按常规处方。
  • 对年轻、疲劳、有通路并发症史、无心衰且路程短的患者,可更主动讨论每周4次方案。
  • 需结合稳健的临床有效性数据与患者选择共同制定个体化透析方案。

局限性

  • 估计基于陈述偏好而非观察行为。
  • 方案接受度预测所依据的治疗获益与危害数据主要来自观察性研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Longer and more frequent hemodialysis sessions are associated with both benefits and harms. However, their relative importance to patients and how they influence acceptability for patients have not been quantified. STUDY DESIGN: Discrete-choice experiment in which a scenario followed by 12 treatment choice sets were presented to patients in conjunction with varying information about the clinical impact of the treatments offered. SETTING & PARTICIPANTS: Patients with kidney failure treated with maintenance dialysis for≥1 year in 5 UK kidney centers. PREDICTORS: Length and frequency of hemodialysis sessions and their prior reported associations with survival, quality of life, need for fluid restriction, hospitalization, and vascular access complications. OUTCOME: Selection of longer (4.5 hours) or more frequent (4 sessions per week) hemodialysis regimens versus remaining on 3 sessions per week with session lengths of 4 hours. ANALYTICAL APPROACH: Multinomial mixed effects logistic regression estimating the relative influence of different levels of the predictors on the selection of longer and more frequent dialysis, controlling for patient demographic characteristics. RESULTS: Among 183 prevalent in-center hemodialysis patients (mean age of 63.7 years, mean dialysis vintage of 4.7 years), 38.3% (70 of 183) always chose to remain on regimens of 3 sessions per week with session duration of 4 hours. Depicted associations of increasing survival and quality of life, reduced need for fluid restriction, and avoiding additional access complications were all significantly associated with choosing longer or more frequent treatment regimens. Younger age, fatigue, previous experience of vascular access complications, absence of heart failure, and shorter travel time to dialysis centers were associated with preference for 4 sessions per week. Patients expressed willingness to trade up to 2 years of life to avoid regimens of 4 sessions per week or access complications. After applying estimated treatment benefits and harms from existing literature, the fully adjusted model revealed that 27.1% would choose longer regimens delivered 3 times per week and 34.3% would choose 4 hours 4 times per week. Analogous estimates for younger fatigued patients living near their unit were 23.5% and 62.5%, respectively. LIMITATIONS: Estimates were based on stated preferences rather than observed behaviors. Predicted acceptance of regimens was derived from data on treatment benefits and harms largely sourced from observational studies. CONCLUSIONS: Predicted acceptance of longer and more frequent hemodialysis regimens substantially exceeds their use in current clinical practice. These findings underscore the need for robust data on clinical effectiveness of these more intensive regimens and more extensive consideration of patient choice in the selection of dialysis regimens.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Fotheringham J, Vilar E, Bansal T, et al. Patient Preferences for Longer or More Frequent In-Center Hemodialysis Regimens: A Multicenter Discrete Choice Study. Am J Kidney Dis. 2021. PMID: 34699958. doi:10.1053/j.ajkd.2021.09.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。